Cas 101446-85-9,4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide

101446-85-9

Post Buying Request

Basic information

Product Name: 4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide
Synonyms: 4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide
CAS NO:101446-85-9
Molecular Formula:
Molecular Weight: 438.294
EINECS: N/A
Product Categories: N/A
Mol File: 101446-85-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide(101446-85-9)
EPA Substance Registry System: 4-(3-(3,4-dichlorophenyl)ureido)-N-(pyrimidin-2-yl)benzenesulfonamide(101446-85-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 101446-85-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

101446-85-9 Suppliers

Recommended suppliersmore

101446-85-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 101446-85-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,4,4 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 101446-85:
(8*1)+(7*0)+(6*1)+(5*4)+(4*4)+(3*6)+(2*8)+(1*5)=89
89 % 10 = 9
So 101446-85-9 is a valid CAS Registry Number.

101446-85-9Upstream product

101446-85-9Downstream Products

101446-85-9Relevant articles and documents

Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity

Al-Ansary, Ghada H.,Nasr, Tamer,Taha, Heba,Fayad, Walid,Mahgoub, Shahenda

, (2021)

Anti-angiogenesis targeting vascular endothelial growth factor receptor 2 (VEGFR2) has emerged as a vital tool for cancer treatment. In this study, a new series of biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs (3a-l) was desig

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 101446-85-9